Clinical Trial Update: R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining two regimens, R-ACVBP and DA-EPOCH-R, in patients with non-GCB diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• DA-EPOCH-R
• R-ACVBP

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: UNKNOWN